Tag Archive for: eye disease

Roche and Regeneron square off in lucrative eye disease market

,

Analysts expect the companies’ Eylea HD and Vabysmo to generate $13.2 billion between them by 2030 in the vascular endothelial growth A therapy market, as healthcare providers and patients switch from older products.

Read more
/by

Novartis drops eye disease gene therapy from $800M Gyroscope acquisition

Following a Phase II review, Novartis has cut the development of a gene therapy candidate for geographic atrophy. In June, the company sold a dry eye disease drug to Bausch + Lomb for $1.75 billion.

Read more
/by